Squarepoint Ops LLC Hutchmed (China) LTD Transaction History

Squarepoint Ops LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$10.78 - $17.73 $153,464 - $252,404	14,236 New	14,236 $170,000
Q3 2022 Nov 14, 2022	BUY	$8.63 - $15.52 $121,286 - $218,118	14,054 New	14,054 $125,000
Q3 2021 Nov 15, 2021	SELL	$35.66 - $42.94 $745,579 - $897,789	-20,908 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$23.7 - $39.27 $495,519 - $821,057	20,908 New	20,908 $821,000

6.88M

6.2K

1.1K

Ticker HCM
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 172,955,008
Market Cap $2.47B
Description
HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.